| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2025―Jul―30 |
Diagnostic performance and user-friendliness of five rapid antigen tests for severe acute respiratory syndrome coronavirus 2 |
Joakim Hekland, Christine Morken, Elisabet Eriksson Boija, Dår Kristian Kur, Sverre Sandberg, Mette C. Tollånes |
| 2 |
[GO] |
2025―Apr―29 |
Perspectives and insight of Al-Baha city population toward blood donation after pandemics: knowledge, attitude, and practice |
Abdulaziz S. Alghamdi, Jawaher Mohammad Alshehri, Abdullah A. Alzahrani, Ruba O. Almaghrabi, Hadeer Mattar, Alkathiri Afnan, et al. (+2) Hind Al-zahrani, Hayaa M. Alhuthali |
| 3 |
[GO] |
2025―Apr―29 |
COVID-19 and obesity: 2025 perspective on epidemiology, pathogenesis, and public health implications |
Giuseppe Lippi, Camilla Mattiuzzi, Fabian Sanchis-Gomar |
| 4 |
[GO] |
2025―Jan―21 |
Evaluation of circadian rhythm of SARS-CoV-2 interferon-gamma release assay (IGRA) in healthy vaccinated individuals: a case-series |
Laura Pighi, Giuseppe Lippi, Gian Luca Salvagno |
| 5 |
[GO] |
2024―Dec―11 |
COVID-19, influenza A H5N1, monkeypox (mpox): is laboratory medicine ready for the next pandemic? |
Giuseppe Lippi, John G. Rizk |
| 6 |
[GO] |
2024―Jan―17 |
Vitamin D status during the COVID-19 pandemic: a pragmatic approach to measurement and supplementation |
Giuseppe Lippi, Camilla Mattiuzzi |
| 7 |
[GO] |
2023―Oct―30 |
Impact of COVID-19 pandemic on serum 25-hydroxyvitamin D levels in Brazilian patients |
Gabriel Pissolati M. Bretz, João Rodrigo Campos, Adriano Alonso Veloso, Karina Braga Gomes, Adriano Basques Fernandes |
| 8 |
[GO] |
2023―Oct―30 |
Humoral response is enhanced after ipsilateral double intramuscular injection of BNT162b2 COVID-19 vaccine |
Laura Pighi, Brandon M. Henry, Gian Luca Salvagno, Giuseppe Lippi |
| 9 |
[GO] |
2023―Jul―28 |
COVID-19: the global health emergency is over for the WHO, but not yet for laboratory medicine |
Giuseppe Lippi, Mario Plebani |
| 10 |
[GO] |
2023―Jan―05 |
Leukocyte differential and cell population data in the evaluation of SARS-CoV-2 and other infections |
Eloísa Urrechaga, Pedro Pablo España, Ane Uranga, Mónica Fernández, Rana Zeeshan Haider, Luis Garcia de Guadiana, Urko Aguirre |
| 11 |
[GO] |
2023―Jan―04 |
Nationwide analysis of COVID-19 death rate throughout the pandemic in Italy |
Camilla Mattiuzzi, Giuseppe Lippi |
| 12 |
[GO] |
2022―Oct―26 |
COVID-19 diagnostics and early phase clinical trials: challenges and risk mitigation in the Omicron variants era |
Brandon Michael Henry, Giuseppe Lippi |
| 13 |
[GO] |
2022―Aug―29 |
Comparison of SARS-CoV-2 anti-spike IgG and anti-nucleoprotein IgG seroprevalence amongst a pre-vaccine cohort of healthcare workers at an academic medical center in Boston, Massachusetts |
Manisha Cole, Maura C. Dodge, Elizabeth R. Duffy, Jordyn N. Osterland, Susan H. Gawel, Lei Ye, et al. (+8) Kyle de la Cena, Elizabeth J. Ragan, Sarah E. Weber, Elissa M. Schechter-Perkins, Tara C. Bouton, Karen R. Jacobson, Chris Andry, Yachana Kataria |
| 14 |
[GO] |
2022―Jul―19 |
COVID-19 vaccination in patients taking immunosuppressant drugs: what is the best strategy for improving immunogenicity? |
Giuseppe Lippi, Camilla Mattiuzzi, Brandon M. Henry |
| 15 |
[GO] |
2022―Jun―16 |
Is cellular immunity the future key for deciphering and monitoring COVID-19 vaccines efficacy? |
Giuseppe Lippi, Camilla Mattiuzzi, Brandon M. Henry |
| 16 |
[GO] |
2022―Mar―31 |
The landscape of SARS-CoV-2 genomic mutations |
Giuseppe Lippi, Brandon M. Henry |
| 17 |
[GO] |
2021―Sep―01 |
Specific leukocyte differential and morphological alarms a clue for the detection of SARS-CoV-2 infection |
Eloísa Urrechaga, Oihane Bóveda, Milagros Hernández, Blanca García San Vicente, Mónica Fernández, Helena Redín, et al. (+4) Irene Pérez, Cristian Morales-Indiano, María José Alcaide, Luís García de Guadiana |
| 18 |
[GO] |
2021―Jun―16 |
Comparing the performance of two commercial assays for detection of SARS-CoV-2 in samples with low viral load |
Kok-Siong Poon, Nancy Wen-Sim Tee |
| 19 |
[GO] |
2021―May―13 |
Emerging COVID-19 diagnostics in context-what about testing saliva? |
Kok-Siong Poon, Nancy Wen-Sim Tee |
| 20 |
[GO] |
2021―May―13 |
Potential drawbacks of pharmacy-based COVID-19 testing |
Giuseppe Lippi, Brandon Michael Henry, Mario Plebani |
| 21 |
[GO] |
2021―Jan―31 |
Altered lipid profile in patients with COVID-19 infection |
Vincenzo Roccaforte, Massimo Daves, Giuseppe Lippi, Marta Spreafico, Claudio Bonato |
| 22 |
[GO] |
2021―Jan―31 |
The real origin of SARS-CoV-2: does it really matter? |
Giuseppe Lippi, Brandon M. Henry, Fabian Sanchis-Gomar |
| 23 |
[GO] |
2020―Oct―22 |
Assessment of immune response against SARS-CoV-2 at emergency department evaluation in COVID-19 patients |
Justin L. Benoit, Stefanie W. Benoit, James Rose, Jonathan Hoehn, Giuseppe Lippi, Brandon Michael Henry |
| 24 |
[GO] |
2020―Oct―22 |
Challenges of COVID-19 testing in low-middle income countries (LMICs): the case of Malawi |
Steven Munharo, Symon Nayupe, Patrick Mbulaje, Parth Patel, Confidence Banda, Kristine Joy Abordo Gacutno, et al. (+3) Xu Lin, Isaac Thom Shawa, Don Eliseo Lucero-Prisno 3rd |
